跳至主要内容
临床试验/IRCT20100414003706N35
IRCT20100414003706N35尚未招募3 期

Effect of a Menohelp Barij® capsule on early symptoms of menopause: a randomized placebo-controlled trial

Barij Essence Pharmaceutical Company0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50 years 至 59 years(—)
性别
Female

入选标准

  • Aged 50-59 years
  • 12-72 months after last menstrual period
  • Natural menopause
  • Having at least 3 hot flashes daily during one week follow-up
  • Living with husband
  • BMI 18 to 30 kg/m2
  • Having a least 6 years Education

排除标准

  • Contraindications for hormone therapy, including history of breast cancer, endometrial hyperplasia, or any estrogen-related cancers in the woman or her first-degree family
  • Use of hormone therapy during past 3 months
  • Allergy to estrogen or medicinal herbs
  • Any history of cervical cancer, liver diseases, kidney diseases, gastrointestinal diseases, coagulation diseases, depression or hyperthyroidism.
  • Surgery during the past 3 months
  • Chronic diseases requiring treatment including severe hypertension (160/110) and known diabetes, or malabsorption syndrome
  • Myocardial or cerebral infarction over the past 3 months or History of complicated myocardial or cerebral infarction
  • History of venous thrombosis
  • history of known fibromyoma
  • Heavy smoker (more than 15 cigarettes/day)
  • Regular consumption of alcoholic beverages and alcohol dependence

研究者

相似试验